Peter Smith

Peter Smith

Company: Remix Therapeutics

Job title: Co-Founder, President & CEO

Seminars:

Biopharma & Investment Partnerships Panel — Exploring the Future of RNA Investment & Collaborations Space for Small Molecules 11:00 am

The biopharmaceutical sector is considering small molecule medications as a vital component. This community thrives on strategic alliances, which allow for cross-functional sharing of knowledge, skills, and experience across different disciplines to truly advance RNA-targeted small molecule drugs to patients. This session is the ideal opportunity to get face-to-face time with many of the brightest…Read more

day: Day One

Novel Approaches to Reprogram RNA Processing with Small Molecules 9:00 am

Recognizing data science techniques for RNA processing variation analysis in genomic data Using small molecules as research tools in RNA processing Exploiting therapeutic intervention possibilitiesRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.